Fluoxetine and Methylphenidate in Combination for Treatment of Attention Deficit Disorder and Comorbid Depressive Disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 3, Issue 1, 1993, Pages 1-10

  Gammon, G Davis ^a   Brown, Thomas E ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012462350     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.1993.3.1     Document Type: Article

References (45)

1. Baldessarini RJ: Drugs in the treatment of psychiatric disorders. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. Edited by Gilman AF, Rail TW, Nies AS, Taylor P. New York, Pergamon Press, 1990, pp 383-435
2. Baldessarini RJ, Marsh ER, Kula NS: Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain Res 579: 152-156, 1992
3. Barkley RA: Attention Deficit Hyperactivity Disorder: Handbook for Diagnosis and Treatment. New York, Guilford Press, 1990
4. Barrickman L, Noyes R, Kuperman S, Schumacher E, Verda M: Treatment of ADHD with fluoxetine: A preliminary trial. J Am Acad Child Adolesc Psychiatry 30: 762-767, 1991
5. Beasley CM, Masica DN, Potvin JH: Fluoxetine: A review of receptor and functional effects and their clinical implications. Psychopharmacology 107: 1-10, 1992
6. Benloucif S, Galloway MP: Facilitation of dopamine relese in vivo by serotonin agonists: Studies with microdialysis. Eur J Pharmacol 200: 1-8, 1991
7. Biederman J, Jellinek MS: Psychopharmacology in children. N Engl J Med 310: 968-972, 1984
8. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS: A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. J Am Acad Child Adolesc Psychiatry 28: 777-784, 1989a
9. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A: A double-blind placebo controlled study of desipramine in the treatment of ADD: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 28: 903-911, 1989b
10. Biederman J, Newcom J, Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. Am J Psychiatry 148: 564-577, 1991
11. Boulos C, Kutcher S, Gardner D, Young E: An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. J Child Adolesc Psychopharmacol 2: 103-111, 1992
12. Caccia S, Fracasso C, Garattini S, Guiso G, Sarati S: Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain. Neuropharmacology 31: 343-347, 1992
13. Campbell M, Green WH, Deutsch SI: Child and Adolescent Psychopharmacology. Beverly Hills, CA, Sage, 1985
14. Carlson GA, Rapport MD, Kelly KL, Pataki CS: Effects of methylphenidate and lithium on attention and activity level. J Am Acad Child Adolesc Psychiatry 31: 262-270, 1992
15. Chen J, van Praag HM, Gardner EL: Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543: 354-357, 1991
16. Cloninger CR: A systematic method for clinical description and classification of personality variants: A proposal. Arch Gen Psychiatry 44: 573-588, 1987
17. Conners CK: Manual for Conner's Rating Scales. North Tonawanda, NY, Multi-Health Systems, 1990, p 3
18. Donnelly M, Zametkin AJ, Rapoport JL: Treatment of hyperactivity with disipramine: Plasma drug concentrations, cardiovascular effects, plasma and urinary catecholamine levels and clinical response. Clin Pharmacol Ther 39: 72-81, 1986
19. Epstein MA, Shaywitz SE, Shaywitz BA, Woolston JL: Boundaries of attention deficit disorder. J Learning Disabilities 31: 262-270, 1991
20. Garfinkel BD, Wender PH, Sloman L, O'Neill I: Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. J Am Acad Child Psychiatry 22: 343-348, 1983
21. Green WH: Child and Adolescent Psychopharmacology. Baltimore, Williams and Wilkins, 1991
22. Green WH: Nonstimulant drugs in treatment of attention-deficit hyperactivity disorder. In: Attention-Deficit Hyperactivity Disorder. Edited by Weiss G. Child Adolesc Psychiatr Clin N Am 1: 449-465, 1992
23. Greenhill LL: Pharmacologie treatment of attention deficit hyperactivity disorder. In: Pediatrie Psychopharmacology. Edited by Shaffer D. Child Adolesc Psychiatr Clin N Am 1: 1-27, 1992a
24. Greenhill LL: Pharmacotherapy: stimulants. In: Attention-Deficit Hyperactivity Disorder. Edited by Weiss G. Child Adolesc Psychiatr Clin N Am 1: 411-447, 1992b
25. Halperin JM, Newcom JH, Sharma V: Ritalin: Diagnostic comorbidity and attentional measures. In: Ritalin: Theory and Patient Management. Edited by Greenhill LL, Osman BB. New York, Mary Ann Liebert, 1991, pp 15-24
26. Hudson JI, Pope HG: Affective spectrum disorder: Does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 147: 552-564, 1990
27. Hunt RD, Lau S, Ryu J: Alternative therapies for ADHD. In: Ritalin: Theory and Patient Management. Edited by Greenhill LL, Osman BB. New York, Mary Ann Liebert, 1991a, pp 75-95
28. Hunt RD, Mandl L, Lau S, Hughes M: Neurobiological theories of ADHD and Ritalin. In: Ritalin: Theory and Patient Management. Edited by Greenhill LL, Osman BB. New York, Mary Ann Lieben, 1991b, pp 267-287
29. Kelland MD, Freeman AS, Chiodo LA: Serotonergic afferent regulation of basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J Pharmacol Exp Ther 253: 803-811, 1990
30. King RA, Riddle MA, Chappell PB, Hardin MT, Anderson GM, Lombroso P, Scahill L: Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 30: 179-186, 1991
31. Kovacs M: Children's Depressive Inventory. Psychopharmacol Bull 21: 995-1000, 1985
32. Linnoila VMI, Virkkunen M: Aggression, suicidality and serotonin. J Clin Psychiatry 53(Supplement, Oct):46-51, 1992
33. Livingston RL, Dykman RA, Ackerman PT: Psychiatric comorbidity and response to two doses of methylphenidate in children with attention deficit disorders. J Child Adolesc Psychopharmacol 2: 115-122, 1992
34. Medical Letter: Sudden death in children treated with a tricyclic antidepressant. Med Lett Drug Ther 32: 53, 1990
35. Popper CW, Elliott GR: Sudden death and tricyclic antidepressants: Clinical considerations for children. J Child Adolesc Psychopharmacol 1: 125-132, 1990
36. Renshaw PF, Guimaraes AR, Fava M, Rosenbaum JF, Pearlman JD, Flood JG, Puopolo PR, Clancy K, Gonzalez RG: Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration. Am J Psychiatry 149: 1592-1594, 1992
37. Riddle MA, Brown N, Dzubinski D, Jetmalani AN, Law Y, Woolston J: Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 28: 567-588, 1989
38. Riddle MA, Hardin MT, King RA, Scahill L, Woolston J: Fluoxetine treatment of children and adolescents with Tourette's and obsessive-compulsive disorders: Preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 29: 45-48, 1990
39. Riddle MA, King RA, Hardin MT, Scahill L, Ort SI, Chappell P, Rasmussen A, Leckman JF: Behavioral side effects of fluoxetine in children and adolescents. J Child Adolesc Psychopharmacol 1: 193-198, 1990/91
40. Riddle MA, Nelson JC, Kleinman CS, Rasmussen A, Leckman JF, King RA, Cohen DJ: Sudden death in children receiving Norpramin: A review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 30: 104-108, 1991
41. Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ: Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 31: 1062-1069, 1992
42. Serra G, Collu M, D'Aquila PS, De Montis GM, Gessa GL: Possible role of dopamine Dl receptor in the behavioral supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Res 527: 234-243, 1990
43. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Ahluwalia S: A children's global assessment scale. Arch Gen Psychiatry 40: 1228-1234
44. Shaffer D, Schwab-Stone M, Fisher P, Cohen P, Piacentini JC, Davies M, Conners CK, Regier D: Revised version of the diagnostic interview schedule for children (DISC-R): I. Preparation, field testing, and acceptability. J Am Acad Child Adolesc Psychiatry, in press, 1983
45. Wender PH: Attention deficit hyperactivity disorder. In: Modern Perspectives in Clinical Psychiatry. Edited by Howells JG. New York, Brunner/Mazel, 1988, pp 149-169